Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Berberine is an Effective Insulin Sensitizer and Improves Homeostasis of Metabolic and Hormonal Disorders in Women With Polycystic Ovary Syndrome: a Novel Treatment Strategy for PCOS

NCT04932070 is registered in ClinicalTrials.gov with Azienda di Servizi alla Persona di Pavia as lead sponsor.

NCT NCT04932070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04932070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Berberine is an Effective Insulin Sensitizer and Improves Homeostasis of Metabolic and Hormonal Disorders in Women With Polycystic Ovary Syndrome: a Novel Treatment Strategy for PCOS
Lead sponsor
Azienda di Servizi alla Persona di Pavia
Phase
Not applicable
Overall status
Completed
Start date
September 5, 2020
Completion date
January 26, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

berberine, polycystic ovary syndrome